Xspray Pharma Secures Licensing Agreement with Handa Therapeutics
Xspray Pharma announces a licensing agreement with Handa Therapeutics to commercialize dasatinib in the U.S. and Asia.
Pharmaceuticals
Top stories
All pharmaceuticals news
Xspray Pharma Secures Licensing Agreement with Handa Therapeutics
Xspray Pharma announces a licensing agreement with Handa Therapeutics to commercialize dasatinib in the U.S. and Asia.